Search all trials

Find therapies in clinical trials near you – page 301

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Cystic fibrosis

Not recruiting

Registered drugNo placebo

Study on Long-term Safety and Efficacy of Elexacaftor, Tezacaftor, and Ivacaftor for Cystic Fibrosis in Patients Aged 12 Months and Older

Registered drugNo placebo

Germany

Participants:0–17 years
Substances:Elexacaftor

Contact Research Centre

Hormone-refractory prostate cancer+1

Not recruiting

Registered drug

Study on Talazoparib and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Enzalutamide

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of Luveltamab Tazevibulin (STRO-002) for Infants and Children Under 12 with Acute Myeloid Leukemia (AML)

InvestigationalNo placebo

Germany

Participants:0–17 years
Substances:Stro-002

Contact Research Centre

Multiple sclerosis

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis

Registered drug

Germany

Participants:18–64 years
Substances:Colestyramine

Contact Research Centre

Hodgkin's disease+6

Not recruiting

Registered drugNo placebo

Study of Cobolimab and Dostarlimab for Children and Young Adults with Newly Diagnosed or Relapsed/Refractory Tumors

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years
Substances:Cobolimab

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Upadacitinib and Dupilumab for Children Aged 2 to 12 with Moderate to Severe Atopic Dermatitis

Registered drugNo placebo

Germany

Participants:0–17 years
Substances:Dupilumab

Contact Research Centre

Metastatic malignant melanoma

Not recruiting

Registered drugNo placebo

Study of Tucidinostat and Nivolumab for Patients with Advanced Melanoma Not Treated with PD-1 or PD-L1 Inhibitors

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on Brigatinib, Ceritinib, and Alectinib for Patients with Advanced ALK+ Non-Small Cell Lung Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Alectinib

Contact Research Centre

Post-traumatic stress disorder

Not recruiting

Registered drug

Evaluation of clonidine and doxazosin for treating nightmares in adults with Post-traumatic Stress Disorder

Registered drug

Germany

Participants:18–64 years
Substances:Doxazosin

Contact Research Centre

Cervix carcinoma

Not recruiting

Registered drugNo placebo

Study on Atezolizumab, Bevacizumab, and Chemotherapy for Patients with Advanced Cervical Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing ONC-392 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After PD-1/PD-L1 Inhibitor Treatment

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

Ataxia telangiectasia

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effects of EryDex with Dexamethasone Sodium Phosphate for Patients with Ataxia Telangiectasia

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years
Substances:Dexamethasone Sodium Phosphate

Contact Research Centre

Find therapies in clinical trials near you – page 301

3 649 trials match your criteria

Cystic fibrosis

Study on Long-term Safety and Efficacy of Elexacaftor, Tezacaftor, and Ivacaftor for Cystic Fibrosis in Patients Aged 12 Months and Older

Hormone-refractory prostate cancer+1

Study on Talazoparib and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Acute myeloid leukaemia

Study on the Safety and Effectiveness of Luveltamab Tazevibulin (STRO-002) for Infants and Children Under 12 with Acute Myeloid Leukemia (AML)

Multiple sclerosis

Study on the Effectiveness and Safety of Frexalimab and Teriflunomide in Adults with Relapsing Multiple Sclerosis

Hodgkin's disease+6

Study of Cobolimab and Dostarlimab for Children and Young Adults with Newly Diagnosed or Relapsed/Refractory Tumors

Dermatitis atopic

Study on the Safety and Effectiveness of Upadacitinib and Dupilumab for Children Aged 2 to 12 with Moderate to Severe Atopic Dermatitis

Metastatic malignant melanoma

Study of Tucidinostat and Nivolumab for Patients with Advanced Melanoma Not Treated with PD-1 or PD-L1 Inhibitors

Non-small cell lung cancer

Study on Brigatinib, Ceritinib, and Alectinib for Patients with Advanced ALK+ Non-Small Cell Lung Cancer

Post-traumatic stress disorder

Evaluation of clonidine and doxazosin for treating nightmares in adults with Post-traumatic Stress Disorder

Cervix carcinoma

Study on Atezolizumab, Bevacizumab, and Chemotherapy for Patients with Advanced Cervical Cancer

Non-small cell lung cancer metastatic

Study Comparing ONC-392 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After PD-1/PD-L1 Inhibitor Treatment

Ataxia telangiectasia

Study on the Safety and Effects of EryDex with Dexamethasone Sodium Phosphate for Patients with Ataxia Telangiectasia

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.